ENHABIT INC (EHAB) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:EHAB - US29332G1022 - Common Stock
10.52 USD
-0.37 (-3.4%)
10.6 USD
+0.08 (+0.76%)
Overall EHAB gets a fundamental rating of 4 out of 10. We evaluated EHAB against 102 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of EHAB while its profitability can be described as average. EHAB has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year EHAB was profitable.
- In the past year EHAB had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: EHAB reported negative net income in multiple years.
- EHAB had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- EHAB has a Return On Assets (-0.97%) which is in line with its industry peers.
- EHAB's Return On Equity of -2.10% is in line compared to the rest of the industry. EHAB outperforms 51.96% of its industry peers.
- EHAB has a Return On Invested Capital of 4.51%. This is comparable to the rest of the industry: EHAB outperforms 51.96% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for EHAB is significantly below the industry average of 9.21%.
- The 3 year average ROIC (3.74%) for EHAB is below the current ROIC(4.51%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.97% | ||
| ROE | -2.1% | ||
| ROIC | 4.51% |
ROA(3y)-7%
ROA(5y)-1.92%
ROE(3y)-15.77%
ROE(5y)-6.79%
ROIC(3y)3.74%
ROIC(5y)4.76%
1.3 Margins
- EHAB has a Operating Margin of 5.96%. This is in the better half of the industry: EHAB outperforms 65.69% of its industry peers.
- In the last couple of years the Operating Margin of EHAB has declined.
- EHAB has a better Gross Margin (48.98%) than 74.51% of its industry peers.
- EHAB's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | N/A | ||
| GM | 48.98% |
OM growth 3Y-29.61%
OM growth 5Y-4.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-1.19%
2. Health
2.1 Basic Checks
- EHAB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- EHAB has more shares outstanding than it did 1 year ago.
- The debt/assets ratio for EHAB is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.73, we must say that EHAB is in the distress zone and has some risk of bankruptcy.
- EHAB has a Altman-Z score (1.73) which is comparable to the rest of the industry.
- The Debt to FCF ratio of EHAB is 8.01, which is on the high side as it means it would take EHAB, 8.01 years of fcf income to pay off all of its debts.
- EHAB's Debt to FCF ratio of 8.01 is in line compared to the rest of the industry. EHAB outperforms 54.90% of its industry peers.
- A Debt/Equity ratio of 0.78 indicates that EHAB is somewhat dependend on debt financing.
- EHAB's Debt to Equity ratio of 0.78 is in line compared to the rest of the industry. EHAB outperforms 49.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | 8.01 | ||
| Altman-Z | 1.73 |
ROIC/WACC0.48
WACC9.47%
2.3 Liquidity
- EHAB has a Current Ratio of 1.58. This is a normal value and indicates that EHAB is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.58, EHAB is in the better half of the industry, outperforming 61.76% of the companies in the same industry.
- A Quick Ratio of 1.58 indicates that EHAB should not have too much problems paying its short term obligations.
- EHAB's Quick ratio of 1.58 is fine compared to the rest of the industry. EHAB outperforms 64.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.58 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 91.30% over the past year.
- EHAB shows a small growth in Revenue. In the last year, the Revenue has grown by 1.02%.
- Measured over the past years, EHAB shows a decrease in Revenue. The Revenue has been decreasing by -1.07% on average per year.
EPS 1Y (TTM)91.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%466.67%
Revenue 1Y (TTM)1.02%
Revenue growth 3Y-2.21%
Revenue growth 5Y-1.07%
Sales Q2Q%3.94%
3.2 Future
- EHAB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.82% yearly.
- The Revenue is expected to grow by 5.22% on average over the next years.
EPS Next Y165.2%
EPS Next 2Y64.92%
EPS Next 3Y40.96%
EPS Next 5Y7.82%
Revenue Next Year2.37%
Revenue Next 2Y3.26%
Revenue Next 3Y3.62%
Revenue Next 5Y5.22%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 23.91, which indicates a rather expensive current valuation of EHAB.
- Based on the Price/Earnings ratio, EHAB is valued a bit cheaper than 63.73% of the companies in the same industry.
- EHAB is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
- EHAB is valuated rather expensively with a Price/Forward Earnings ratio of 18.42.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of EHAB indicates a somewhat cheap valuation: EHAB is cheaper than 70.59% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 24.29. EHAB is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.91 | ||
| Fwd PE | 18.42 |
4.2 Price Multiples
- 70.59% of the companies in the same industry are more expensive than EHAB, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, EHAB is valued cheaper than 87.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.2 | ||
| EV/EBITDA | 10.69 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as EHAB's earnings are expected to grow with 40.96% in the coming years.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y64.92%
EPS Next 3Y40.96%
5. Dividend
5.1 Amount
- EHAB does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
10.52
-0.37 (-3.4%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)03-03 2026-03-03/amc
Inst Owners104.3%
Inst Owner ChangeN/A
Ins Owners2.33%
Ins Owner Change8.63%
Market Cap532.42M
Revenue(TTM)1.05B
Net Income(TTM)-11.90M
Analysts76.36
Price Target10.81 (2.76%)
Short Float %3.41%
Short Ratio3.47
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.12%
Min EPS beat(2)23.34%
Max EPS beat(2)38.89%
EPS beat(4)3
Avg EPS beat(4)21.77%
Min EPS beat(4)-28.32%
Max EPS beat(4)53.19%
EPS beat(8)6
Avg EPS beat(8)34.93%
EPS beat(12)7
Avg EPS beat(12)12.51%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.11%
Min Revenue beat(2)-3.27%
Max Revenue beat(2)-0.95%
Revenue beat(4)0
Avg Revenue beat(4)-2.69%
Min Revenue beat(4)-4.23%
Max Revenue beat(4)-0.95%
Revenue beat(8)0
Avg Revenue beat(8)-3.24%
Revenue beat(12)0
Avg Revenue beat(12)-3.7%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.58%
PT rev (3m)13.07%
EPS NQ rev (1m)3.6%
EPS NQ rev (3m)6.98%
EPS NY rev (1m)0%
EPS NY rev (3m)10.53%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-0.48%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)-0.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.91 | ||
| Fwd PE | 18.42 | ||
| P/S | 0.51 | ||
| P/FCF | 9.2 | ||
| P/OCF | 8.55 | ||
| P/B | 0.94 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.69 |
EPS(TTM)0.44
EY4.18%
EPS(NY)0.57
Fwd EY5.43%
FCF(TTM)1.14
FCFY10.87%
OCF(TTM)1.23
OCFY11.7%
SpS20.7
BVpS11.2
TBVpS-7.48
PEG (NY)0.14
PEG (5Y)N/A
Graham Number10.53
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.97% | ||
| ROE | -2.1% | ||
| ROCE | 5.71% | ||
| ROIC | 4.51% | ||
| ROICexc | 4.76% | ||
| ROICexgc | 54.35% | ||
| OM | 5.96% | ||
| PM (TTM) | N/A | ||
| GM | 48.98% | ||
| FCFM | 5.53% |
ROA(3y)-7%
ROA(5y)-1.92%
ROE(3y)-15.77%
ROE(5y)-6.79%
ROIC(3y)3.74%
ROIC(5y)4.76%
ROICexc(3y)3.81%
ROICexc(5y)4.84%
ROICexgc(3y)39.56%
ROICexgc(5y)58.49%
ROCE(3y)4.73%
ROCE(5y)6.02%
ROICexgc growth 3Y-27.94%
ROICexgc growth 5YN/A
ROICexc growth 3Y-21.68%
ROICexc growth 5YN/A
OM growth 3Y-29.61%
OM growth 5Y-4.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-1.19%
F-Score7
Asset Turnover0.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | 8.01 | ||
| Debt/EBITDA | 5.02 | ||
| Cap/Depr | 17.25% | ||
| Cap/Sales | 0.42% | ||
| Interest Coverage | 1.77 | ||
| Cash Conversion | 70.88% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.58 | ||
| Altman-Z | 1.73 |
F-Score7
WACC9.47%
ROIC/WACC0.48
Cap/Depr(3y)51.64%
Cap/Depr(5y)35.82%
Cap/Sales(3y)1.58%
Cap/Sales(5y)1.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%466.67%
EPS Next Y165.2%
EPS Next 2Y64.92%
EPS Next 3Y40.96%
EPS Next 5Y7.82%
Revenue 1Y (TTM)1.02%
Revenue growth 3Y-2.21%
Revenue growth 5Y-1.07%
Sales Q2Q%3.94%
Revenue Next Year2.37%
Revenue Next 2Y3.26%
Revenue Next 3Y3.62%
Revenue Next 5Y5.22%
EBIT growth 1Y60.82%
EBIT growth 3Y-31.17%
EBIT growth 5Y-5.31%
EBIT Next Year78.82%
EBIT Next 3Y23.25%
EBIT Next 5YN/A
FCF growth 1Y632.91%
FCF growth 3Y-26.15%
FCF growth 5Y0%
OCF growth 1Y25.6%
OCF growth 3Y-25.39%
OCF growth 5Y-2.96%
ENHABIT INC / EHAB FAQ
What is the fundamental rating for EHAB stock?
ChartMill assigns a fundamental rating of 4 / 10 to EHAB.
What is the valuation status for EHAB stock?
ChartMill assigns a valuation rating of 6 / 10 to ENHABIT INC (EHAB). This can be considered as Fairly Valued.
Can you provide the profitability details for ENHABIT INC?
ENHABIT INC (EHAB) has a profitability rating of 4 / 10.
What is the expected EPS growth for ENHABIT INC (EHAB) stock?
The Earnings per Share (EPS) of ENHABIT INC (EHAB) is expected to grow by 165.2% in the next year.